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and treatment of diabetes 
Klaus Gebel,1 Hidde P van der Ploeg,1 Maria Fiatarone Singh2 and Adrian Bauman1
This chapter is concerned with the role of physical activity and exercise prescription as 
components in the prevention and treatment of diabetes. First, the evidence for the 
diabetes-specific health benefits of physical activity is summarised and the physiological 
mechanisms are pointed out. Studies of medical comorbidities of diabetes are discussed. 
Recommendations for physical activity and exercise in the prevention and control of type 2 
diabetes are provided, and challenges in the implementation of such strategies are discussed.
The health benefits of regular moderate-intensity physical activity are well known. In 
particular, epidemiological evidence has shown that an active lifestyle is beneficial in the 
prevention and treatment of more than 20 health conditions including coronary heart 
disease, stroke, type 2 diabetes and some cancers [1–3].
Physical activity is defined as body movement produced by skeletal muscle that results 
in energy expenditure above resting level [2], and can be accumulated at any time, for 
example during work, housework, transportation or during leisure time. Exercise is a subset 
of ‘leisure time physical activity’ that is usually structured, planned, repetitive, and has the 
purpose of providing recreation, improving or maintaining physical fitness, or enhancing 
other components of health or wellbeing (see Figure 1). Physical fitness includes cardio-
respiratory fitness, muscle strength, body composition and flexibility [4, 5]. Metabolic 
fitness is also increasingly recognised as an important component of fitness which is closely 
related to physical activity levels, as well as cardiovascular and musculoskeletal fitness [6].
For the general adult population the American College of Sports Medicine recommends 
to accumulate at least 30 minutes of at least moderate-intensity physical activity on five, 
preferably all, days of the week, or vigorous-intensity aerobic physical activity for at least 
20 minutes on three days per week [1, 3, 7]. However, even though physical activity confers 
numerous health benefits, large parts of the adult population are not sufficiently active [8–13].
1  Sydney School of Public Health, University of Sydney.
2  Discipline of Exercise and Sports Science, Faculty of Health Science, University of Sydney.
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Type 2 diabetes is related to genetic, environmental and behavioural factors. Particularly, 
lack of physical activity and visceral obesity are considered to be major contributors to the 
global diabetes epidemic.
Figure 1. Energy expenditure in humans subdivided into sedentary behaviour, physical 
activity and the various forms of exercise.
This chapter is concerned with the role of physical activity and exercise prescription as 
components in the prevention and treatment of diabetes [14, 15]. First, the evidence for the 
diabetes-specific health benefits of physical activity will be summarised. Recommendations 
for physical activity and exercise in the prevention and control of type 2 diabetes will be 
provided, and challenges in the implementation of such strategies will be discussed.
Prevention of type 2 diabetes
Physical inactivity and overweight/obesity are both risk factors for the development of type 
2 diabetes. Regular physical activity improves insulin sensitivity, and reduces glucose levels 
[16]. The role of obesity in the development of diabetes type 2 is likely to work through 
adipocytes releasing adipocytokines into the circulation, including leptin, adipsin, resistin 
and interleukin-6 (IL-6) [17], some of which are associated with insulin resistance [18, 
19]. There are indications that obesity plays a larger role than physical activity in the 
development of diabetes [20–22]. However, physical activity has been shown to be beneficial 
in the prevention of type 2 diabetes independent of weight loss [16]. Besides the beneficial 
effects of physical activity on the development of type 2 diabetes, it can also be effective in 
prevention of the metabolic syndrome [16, 23], and during pregnancy in the prevention of 
gestational diabetes [24, 25], and has independent benefits in reducing cardiovascular risk 
[1]. The following sections summarise the evidence from observational and intervention 
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studies on the role of physical activity in the primary and secondary prevention of type 2 
diabetes.
Diabetes prevention evidence: observational studies
The evidence for primary prevention comes from observational epidemiology; these are 
usually from large population-based cohort studies that examined whether exposure to 
occupational, commuting and leisure-time physical activity was related to the subsequent 
risk of developing type 2 diabetes.
A meta-analysis synthesised the findings from ten prospective cohort studies from the US, 
the UK, Finland and Japan regarding the exposure to moderate-intensity physical activity 
and the risk of developing type 2 diabetes [26]. These studies included 301 221 participants 
and 9367 incident cases of diabetes. The pooled relative risk for diabetes in those who 
regularly engaged in moderate physical activity was 0.69 (95% CI 0.58–0.83) compared 
with inactive participants. Similarly, the relative risk of those who walked regularly was 
0.70 (0.58–0.84) compared with almost no walking. The associations remained significant 
when adjusted for BMI [26].
Likewise, a recent report summarised the results from 25 prospective cohort studies and 
found a similar inverse relationship between physical activity and diabetes incidence. This 
relationship applied to men and women, different age groups and ethnicities. The reduction 
in relative risk for type 2 diabetes ranged from 15%–60% for those that were physically 
active compared with their more inactive peers [16]. It also appears that several domains 
of physical activity (occupational, commuting and leisure-time physical activity) are all 
inversely related to the risk of developing type 2 diabetes. Based on these studies, at least 30 
minutes per day (210 minutes per week) of at least moderate-intensity physical activity is 
sufficient to achieve a significant reduction in diabetes incidence [16].
A new area of research has developed around total ‘sitting’ time. These studies have 
indicated that prolonged sitting time, including measures of television watching, might 
be associated with the risk of developing type 2 diabetes, independent of leisure-time 
physical activity [27–29]. Furthermore, breaks in sitting time have been associated with 
improvements in waist circumference, triglycerides, and two-hour plasma glucose levels 
[30]. Two large cohort studies have observed that each two-hour increment per day in 
watching TV, as a proxy measure of sitting time, was associated with a 14%–20% increase 
in diabetes incidence, even after adjustment for physical activity participation [31, 32].
Diabetes prevention: the evidence from intervention studies
The strongest evidence for the benefits of physical activity and exercise in the prevention of 
type 2 diabetes comes from community-based lifestyle intervention trials. To date, at least 
six randomised trials have examined whether lifestyle interventions, including physical 
activity, reduce the risk of developing type 2 diabetes among adults with impaired glucose 
tolerance. These trials are:
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•	 Diabetes Prevention Program (DPP), US
•	 Diabetes Prevention Study (DPS), Finland
•	 Da Qing IGT and Diabetes Study (DQS), China
•	 Diabetes Prevention Program (IDPP), India
•	 Diabetes Prevention Program (JDPP), Japan
•	 Västerbotten Intervention Program (VIP), Sweden.
All these trials demonstrated that structured lifestyle modification programs reduced 
the incidence of type 2 diabetes compared to controls or usual care. For these programs, 
exercise was usually an independent predictor of improved metabolic control or reduced 
diabetes incidence, and varied modes of exercise were usually included (see Table 1).
In the Da Qing study in China, 577 middle-aged men and women with impaired glucose 
tolerance were randomised to a diet only, exercise only, diet and exercise, or control group. 
The unsupervised exercise prescription ranged from 140 minutes per week for those over 
50 years to 280 minutes per week for younger participants. After six years, the diet, exercise, 
and combined diet and exercise interventions achieved 31%, 46%, and 42% reductions in 
the risk of developing diabetes compared with the control group [33]. At 20-year follow-up, 
a sustained preventive benefit was still observed, with the likelihood of diabetes 43% lower 
among those allocated to the lifestyle interventions [34].
In the US Diabetes Prevention Program (DPP) 3324 overweight and obese participants 
with impaired glucose tolerance were randomised into three groups (placebo, metformin 
therapy, and lifestyle). The lifestyle modification intervention aimed to increase physical 
activity to at least 150 minutes per week (primarily unsupervised brisk walking, but with 
availability of two sessions of supervised exercise per week) and reduce weight by at least 
7%. After a follow-up of three years the lifestyle intervention showed a 58% reduction in 
the risk of developing diabetes compared to the placebo group, while the metformin group 
had a risk reduction of only 31% [35]. At ten-year follow-up, compared to controls, the 
lifestyle intervention maintained a 34% lowered risk of diabetes, and the metformin group 
maintained an 18% reduction [36].
The Finnish Diabetes Prevention Study (n = 522) showed similar results to the US DPP. 
This lifestyle intervention comprised 210 minutes per week of exercise (including three 
sessions per week of supervised aerobic and resistance/power training) and diet-induced 
weight loss of 5%–7%, resulting in a four-year diabetes risk reduction of 58% (p <.001). In 
this study, those who failed to meet the weight-loss goal, but accumulated four hours of 
weekly moderate exercise, had a significantly lower risk of diabetes than the control group 
[37]. Three years after the program, intervention group participants maintained many 
lifestyle changes and their risk for diabetes was still 36% lower than among controls [38].
Ta
bl
e 
1.
 L
ife
st
yl
e 
ch
an
ge
 g
oa
ls
 in
 th
e 
in
te
rv
en
tio
n 
gr
ou
ps
 in
 d
ia
be
te
s 
pr
ev
en
tio
n 
pr
og
ra
m
s.
 A
da
pt
ed
 fr
om
 B
ak
er
 M
 e
t a
l. 
2
01
1.
St
ud
y 
(c
ou
nt
ry
)
Ex
er
ci
se
 /
 p
hy
si
ca
l a
ct
iv
ity
D
ie
t /
 n
ut
rit
io
n
D
ur
at
io
n 
(m
in
/w
k)
In
te
ns
ity
St
ru
ct
ur
ed
 
ex
er
ci
se
Su
pe
rv
is
ed
 
ex
er
ci
se
Ae
ro
bi
c 
ac
tiv
ity
PR
T 
ac
tiv
ity
Ж
 
Oc
cu
pa
ti-
on
al
 a
ct
iv
ity
Po
rt
io
n 
co
nt
ro
l
Fa
t
Al
co
ho
l
Fi
br
e
D
PP
 (U
S)
≥1
5
0
*
M
od
er
at
e









D
PS
 
(F
in
la
nd
)
≥2
10
M
od
er
at
e 
to
 
st
re
nu
ou
s









D
Q
S 
(C
hi
na
)
≥3
5
–
4
2
0
†
Li
gh
t t
o 
ve
ry
 
st
re
nu
ou
s









ID
PP
 (I
nd
ia
)
≥2
10
M
od
er
at
e
✓








JD
PP
 (J
ap
an
)
21
0
–
2
8
0
M
od
er
at
e









VI
P 
(S
w
ed
en
)
≥1
5
0
‡
Lo
w
-M
od
er
at
e









*
 E
ne
rg
y 
ex
pe
nd
itu
re
 ≥
7
0
0
 k
ca
l/
w
ee
k 
w
as
 th
e 
pr
im
ar
y 
ob
je
ct
iv
e,
 a
nd
 th
e 
ta
rg
et
 v
ol
um
e 
(m
in
/w
ee
k)
 w
as
 a
llo
w
ed
 to
 b
e 
in
cr
ea
se
d/
de
cr
ea
se
d 
ba
se
d 
on
 th
e 
in
te
ns
ity
 o
f 
ac
tiv
iti
es
 p
er
fo
rm
ed
.
† 
3
5
–
21
0
 m
in
/w
ee
k 
fo
r p
er
so
ns
 ≥
5
0
 y
ea
rs
; 7
0
–
4
2
0
 m
in
/w
ee
k 
fo
r p
er
so
ns
 <
5
0
 y
ea
rs
. 
‡
 2
.5
 h
ou
rs
 p
er
 d
ay
 p
re
sc
rib
ed
 a
s 
su
pe
rv
is
ed
 e
xe
rc
is
e 
in
 th
e 
fir
st
 m
on
th
.
PR
T 
=
 P
ro
gr
es
si
ve
 re
si
st
an
ce
 tr
ai
ni
ng
; D
PP
 =
 D
ia
be
te
s 
Pr
ev
en
tio
n 
Pr
og
ra
m
 (U
S)
; D
PS
 =
 D
ia
be
te
s 
Pr
ev
en
tio
n 
St
ud
y 
(F
in
la
nd
); 
D
Q
S 
=
 D
a 
Q
in
g 
IG
T 
an
d 
D
ia
be
te
s 
St
ud
y 
(C
hi
na
); 
ID
PP
 =
 D
ia
be
te
s 
Pr
ev
en
tio
n 
Pr
og
ra
m
 (I
nd
ia
); 
JD
PP
 =
 D
ia
be
te
s 
Pr
ev
en
tio
n 
Pr
og
ra
m
 (J
ap
an
); 
VI
P 
=
 V
äs
te
rb
ot
te
n 
In
te
rv
en
tio
n 
Pr
og
ra
m
 (S
w
ed
en
).
Ж
 P
R
T:
 p
ro
gr
es
si
ve
 re
si
st
an
ce
 tr
ai
ni
ng
.
280 • A modern epidemic
The Indian Diabetes Prevention Study (n = 531) comprised a physical activity target of 
unsupervised brisk walking for at least 30 minutes each day (210 min/week). After three 
years the relative risk reduction for diabetes was 28.5% for the lifestyle intervention, 26.4% 
for metformin, and 28.2% for the combination of both interventions compared to the 
control group [39]. 
A non-randomised lifestyle intervention among middle-aged males in Sweden included 
a substantial physical activity component. Over six years of follow-up, the lifestyle 
intervention achieved a 63% risk reduction for the development of diabetes compared 
with the control group [40]. A more recent Swedish study randomised 194 middle-aged 
adults with impaired glucose tolerance to lifestyle intervention or usual care, and observed 
metabolic indicators and insulin resistance improvements at 12 months, with some 
improvements maintained at five years (VIP program) [41].
The Japanese Diabetes Prevention Program (JDPP) followed 458 men for four years. Twenty 
percent of participants were randomised to an intensive intervention group of diet and 
physical activity advice, and the others were assigned to the standard intervention (control) 
group. The JDPP prescribed 30 to 40 minutes per day (ie 210 to 280 minutes per week) of 
unsupervised moderate intensity physical activity [42]. This prescription included sport 
and active commuting, and reduced diabetes incidence by 68% at four-year follow-up.
Summary of diabetes prevention evidence
The net results of these diverse trials in people at risk of diabetes show a clear secondary 
prevention benefit of lifestyle interventions [43]. There appear to be independent protective 
benefits of both weight loss and physical activity. A recent Cochrane review summarised 
these results, and in a meta-analysis of randomised controlled diabetes prevention trials, 
showed that exercise and diet interventions reduced the risk of type 2 diabetes by 37% [44]. 
Although most lifestyle trials did not distinguish benefits attributed to weight loss or to 
physical activity [45], several studies did observe effects of activity independent of weight 
loss, suggesting these risk factors partly operate independently of each other [33, 39].
Limitations of these trials include self-report of physical activity participation. However, in 
epidemiological studies where measurement error in exposure occurs, the observed relative 
risk is likely to underestimate the true relative risk, so these ‘physical activity self report’ 
estimates are likely to underestimate the preventive relationship between activity and 
diabetes incidence. Objective measurement would be better [46], and in epidemiological 
studies, fitness measures show a strong protective relationship to diabetes incidence [47–
49].
Recommendations for diabetes prevention
For at-risk individuals, a minimum dose of at least 150 minutes per week, and possibly 
substantially more, of ‘at least moderate-intensity physical activity’ is recommended to 
prevent diabetes. This is in addition to recommendations for a healthy diet and weight loss.
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Physical activity advice should form part of every clinical counselling session with 
individuals at risk of diabetes, and a clear plan should be developed. People can accumulate 
physical activity in different settings: through active commuting, and in their leisure time 
through structured or unstructured exercise programs. Higher levels of physical activity, 
up to an hour a day of moderate-intensity activity, yield even greater reductions in the 
incidence of type 2 diabetes [1, 43, 50]. Resistance training regimens, which are important 
in diabetes management, should also be considered, especially for older adults [3], and 
three of the RCTs of diabetes prevention (DPP, DPS, VIP) have specifically included this 
exercise modality. It also appears that long uninterrupted periods of sitting should be 
avoided.
As previously mentioned, obesity is an independent risk factor for diabetes. However, 
while a minimum of 30 minutes of physical activity per day (150 to 210 minutes per week) 
appears to be sufficient for a significant risk reduction in type 2 diabetes, this may not 
be sufficient for weight maintenance or weight loss [3, 51]. At least 60 to 90 minutes of 
moderate-intensity physical activity daily is needed for weight maintenance in previously 
overweight or obese people [51–53]. Therefore, engaging in more than 30 minutes of 
moderate-intensity physical activity per day would not only reduce the risk of developing 
diabetes directly, but for those who are overweight or obese also by influencing body weight 
and improving fat distribution.
1.5 Challenges in implementation
The epidemiological evidence relates to both the primary and secondary prevention of 
diabetes. The primary prevention of diabetes involves a whole-population approach, 
which requires actions in both clinical and community settings. This means that all 
clinical encounters need to recommend physical activity/exercise, in the same way that 
tobacco cessation is almost universally recommended. Unfortunately, many primary 
care physicians remain reluctant to adopt this area of preventive counselling [54]. Advice 
regarding moderate intensity physical activity may have better compliance rates than 
vigorous-intensity prescriptions [55], so that the initial goal is to ensure all sedentary and 
low active individuals reach at least the minimal threshold of 150 minutes of activity each 
week, preferably across five or more days. In addition, clinicians need to become advocates 
for physical activity programs and facilities across the community [56], in the same way 
that they rapidly adopted and disseminated an anti-smoking stance in the 1980s.
The secondary prevention goal requires identification of those at risk for diabetes, which 
is itself a challenge. For these individuals, more structured and evidence-based lifestyle 
advice is important. Patient advice should highlight the importance of physical activity in 
diabetes prevention, and include referral to appropriate structured exercise programs; in 
addition, some increases in incidental lifestyle activities are recommended to increase total 
energy expenditure, including active transport, increasing active chores and being active in 
one’s local environment.
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Management of type 2 diabetes
Apart from its role in the prevention of type 2 diabetes, physical activity and exercise have 
important roles in the treatment and management of diabetes [57–60]. This role remains 
largely unincorporated into mainstream clinical management of type 2 diabetes [61]. 
Given that exercise has an effect as potent as most oral hypoglycaemic agents [62], this is a 
critical gap in clinical care.
In this section, the health benefits of physical activity and exercise for individuals with 
type 2 diabetes will be discussed. Firstly, the evidence for the health benefits from various 
physical activity and exercise interventions for individuals with type 2 diabetes will be 
described. Then, physical activity and exercise recommendations for the care of diabetes 
will be outlined. Lastly, challenges in the implementation of strategies to increase levels of 
physical activity participation among those with diabetes will be discussed.
Diabetes management evidence: aerobic training
The majority of studies on the role of physical activity in the management of type 2 diabetes 
have focused on the effects of aerobic training [63]. Aerobic exercise involves the usage 
of large muscles and relies on aerobic levels of energy expenditure (eg brisk walking, 
cycling, jogging, swimming). Aerobic exercise alone is associated with clinically significant 
reductions in the glycosylated haemoglobin level [64, 65]. The physiological adaptations 
responsible for improvements in glucose control through aerobic training include increased 
capillary density, glucose transport (GLUT4) proteins in muscle, protein kinase B content, 
and glycogen synthase activity, as well as a shift from low-oxidative type 2b muscle fibres 
to moderate-oxidative, more insulin-sensitive type 2a muscle fibres [63, 66], and decreased 
inflammatory cytokines which impair insulin signalling in skeletal muscle [67, 68].
Aerobic training improves fitness levels and insulin sensitivity, and also results in 
redistribution of visceral adiposity [69]. Even in the absence of weight loss, vigorous activity 
can improve insulin sensitivity [70], decrease insulin resistance and reduce arterial stiffness 
[71]. Diabetes markers improved by exercise include insulin resistance, but also HDL and 
lipid profiles, as well as glycosylated haemoglobin levels and systemic inflammation in 
some studies [72, 73].
A meta-analysis pooled the results of seven randomised controlled trials on the effects of 
structured aerobic exercise interventions on cardio-respiratory fitness in adults with type 2 
diabetes (n = 266). Participants in the exercise groups increased their fitness (VO2max) by 
11.8%, compared to 1% in control groups (p < 0.003). Interventions with higher intensities 
tended to yield larger improvements in fitness. Moreover, exercise intensity predicted 
weighted mean difference in glycosylated haemoglobin better than exercise volume [62]. A 
recent large-scale randomised trial from the US (n = 4376 overweight and obese individuals 
with type 2 diabetes) also found increases in cardio-respiratory fitness to be significantly 
higher in a combined physical activity and diet intervention than in a diabetes support and 
education group [74].
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Diabetes management evidence: resistance training
Traditionally, aerobic training has been used as the main exercise modality to manage 
type 2 diabetes [75]. However, in recent years resistance training has been gaining wide 
acceptance as an important strategy in the treatment of diabetes [63]. In resistance training 
muscles work against a resistive load or weight leading to hypertrophy and improved 
muscular strength. With increasing age adults have decreases in muscle mass, functional 
capacity, resting metabolic rate, and increases in adiposity, and insulin resistance. Resistance 
training is associated with improvements in bone mineral density, muscle strength and 
muscle hypertrophy and can thereby help in the prevention of osteoporosis and sarcopenia 
and in the maintenance of functional status [7, 76]. However, only a small number of well-
controlled intervention studies have examined the benefits of resistance training for people 
with type 2 diabetes [63]. The most recent meta-analysis of resistance training by Strasser et 
al. [77] included 13 RCTs in which resistance training reduced glycosylated haemoglobin 
(HbA(1c)) by 0.48% (95% CI –0.76, –0.21; p = 0.0005), fat mass by 2.33 kg (95% CI –4.71, 
0.04; p = 0.05) and systolic blood pressure by 6.19 mmHg (95% CI –11.38, –1.00; p = 
0.02). It has been hypothesised that the improved glucose uptake is not only due to an 
increase in muscle mass that is associated with resistance training, but probably also due 
to qualitative changes in muscles that enhance insulin signalling and thereby sensitivity 
[78]. Furthermore, progressive resistance training (PRT) has been found to positively 
influence insulin resistance [79, 80]. Based on this evidence, resistance training should be 
recommended in the management of type 2 diabetes and metabolic disorders.
The strongest evidence for the health benefits of resistance training in type 2 diabetes 
comes from two trials that used multiple exercises at relatively high intensities and showed 
a decrease in glycosylated haemoglobin of 1.1%–1.2% in the intervention group compared 
to no significant change in the control group [81, 82]. However, even studies that used 
relatively low volumes and intensities of resistance training achieved positive effects on 
glucose control [79, 83–87]. This is particularly important for individuals who are totally 
sedentary and are not likely to participate in programs involving strenuous aerobic or 
resistance training [63]. This could apply to older adults, who may find it difficult to get to, 
or participate in, structured aerobic programs.
Other health benefits of resistance training in diabetes are an improved body composition, 
increases in total fat-free mass, reduced blood pressure [82], improved muscular strength 
[85], lipid profiles [84], bone mineral density and metabolic rate at rest, and a preferential 
mobilisation of visceral and subcutaneous adipose tissue in the abdominal region [63]. 
Resistance training can also help in reducing the required insulin-sensitising medication 
dose and thereby limit side effects [82, 88], and benefits depression [89] and cognitive 
impairment [90], both of which are more prevalent in those with diabetes.
While there is substantial evidence for the health benefits of resistance training for people 
with type 2 diabetes, a Canadian study showed that 88% of individuals with diabetes do not 
carry out resistance training activities [91]. This shows the unrealised potential of wide-
scale interventions to promote resistance training among people with diabetes.
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Diabetes management evidence: aerobic and resistance training
Resistance and aerobic training have similar beneficial effects on insulin sensitivity 
and metabolic control in type 2 diabetes [58, 64, 92]. However, some studies compared 
combinations of both resistance and aerobic exercise versus only one of the two exercise 
modalities. A Canadian study (n = 28) compared the effects of a combined aerobic and 
resistance training program to aerobic training only in postmenopausal women with type 2 
diabetes. There were no differences in weight loss, fitness, or blood lipids, but the combined 
group showed better glucose uptake and larger increases in muscle mass compared to 
the aerobic only group [87]. Similarly, an American study also reported on benefits of 
combining resistance and aerobic training on glycaemic control, fitness and lean tissue 
mass [65]. Another Canadian study showed that while both aerobic and resistance training 
alone were effective in reducing glycosylated haemoglobin, the combination of both exercise 
modalities was more effective [64]. However, in this study, the combined group had twice 
the volume of exercise, which may have been responsible for the added efficacy of this 
treatment, as noted by the authors. Furthermore, an Italian study (n = 120) that combined 
aerobic and resistance training showed more general improvements in cardiovascular risk 
factors than studies that used resistance training only as the intervention [93]. Finally, a 
meta-analysis found that the differences in the benefits of aerobic, resistance and combined 
training for people with diabetes were small. However, combined training generally showed 
advantages over aerobic or resistance training alone [94]. This leads to the optimal clinical 
recommendation of both modalities, but either may be more convenient or accessible for 
different patient groups.
Clinically, there are many patients with multiple comorbidities who cannot tolerate the dose 
of aerobic exercise that has proven effective in RCTs. Resistance training improves aerobic 
capacity, osteoarthritis pain and disability, depression, functional status, gait and balance 
impairments, bone density, and insomnia, thus addressing the spectrum of associated 
clinical disorders in older type 2 adults with diabetes [95], and providing a strong rationale 
for its utility in this condition. Notably, high intensity PRT is feasible even when robust 
aerobic exercise is impossible due to frailty, balance disorders, osteoarthritis or advanced 
peripheral vascular disease for example, making it particularly suitable for the typical older 
adult with type 2 diabetes. In addition, only PRT attenuates the loss of lean tissue (muscle 
and bone) accompanying weight loss diets typically prescribed for overweight adults with 
diabetes [96], thus minimising weight cycling related to lowered basal metabolic rate. By 
contrast, aerobic exercise is not anabolic, and does not increase muscle mass, precluding 
the associated metabolic and clinical benefits such a shift in body composition produces 
[13].
Diabetes management evidence: patho-physiological mechanisms
A Cochrane review and a meta-analysis, both synthesising the results of 14 randomised 
controlled trials of aerobic and resistance exercise programs, found that levels of glycosylated 
haemoglobin were reduced by around 0.6% in the exercise groups, while there were no 
differences between the groups in body mass index [97, 98]. Khaw et al. found that each 
1% increase in glycosylated haemoglobin with levels between 5%–6.9% was associated with 
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a 28% increase in mortality risk, independent of other risk factors, including age, blood 
pressure, serum cholesterol and body mass index [99]. It was suggested that much of the 
excess mortality risk of diabetes in men could be profiled by the biomarker of increased 
glycosylated haemoglobin.
The limited impact on the body mass index in exercising groups may be due to increases in 
muscle mass, that keep body mass relatively constant [97], particularly in trials of resistance 
training. It seems likely that muscle and adipose tissue distribution plays a crucial role in 
glucose metabolism, rather than body mass itself. It has been shown that an increase in 
lean body mass is inversely correlated with changes in glycosylated haemoglobin [83, 100], 
which might be due to increased storage of glucose in the skeletal muscle [76]. Muscle 
hypertrophy is not only associated with an increase in insulin sensitivity, but also with 
an increase in resting metabolic rate, exercise tolerance and functional mobility [65]. 
Furthermore, exercise-induced reductions in abdominal subcutaneous and visceral adipose 
tissue distributions are related to increased insulin sensitivity, without changes in overall 
body weight [69, 87]. Adipose tissue is associated with secretion of adipocytokines, which 
can negatively influence insulin resistance [101]. In conclusion, exercise-induced increases 
in fat-free mass and reductions in adipose tissue, as well as shifts in anabolic-catabolic 
hormonal profile are beneficial for glucose control and other aspects of metabolic health, 
regardless of changes in body weight. These relationships are demonstrated in Figure 2.
Summary of diabetes management evidence
Numerous trials have demonstrated the health benefits of physical activity and exercise 
in the treatment of type 2 diabetes. Physical activity is associated with improved insulin 
sensitivity and glucose control independent of weight loss [97]. Moreover, regular physical 
activity leads to a decrease in blood lipids and blood pressure, and has independent 
protective benefits on coronary heart disease risk, which is elevated among those with 
diabetes. The benefits achieved by aerobic and resistance training seem apparent shortly 
after starting a structured exercise program. Activity needs to be regular; the frequency of 
exercise sessions is optimally at least three or more times per week to maintain metabolic 
benefits. This is due to the known acute bout effect of exercise on insulin resistance, which 
wanes between 24 and 96 hours after exercise, and is responsible for a portion of the long-
term training benefits [102]. In general, both higher volumes and higher intensities of 
exercise result in greater metabolic improvements [43].
There are a few limitations in studies on physical activity in diabetes management, including 
trials in small selected samples. Similar to studies about the prevention of diabetes, some 
trials used interventions of combined physical activity, nutrition and medication [74, 103]. 
In order to isolate the independent effect of physical activity in diabetes management 
interventions, one needs to compare exercise alone versus other therapeutic modalities 
[97]. Current trials are underway examining the long-term efficacy of exercise and dietary 
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interventions in the treatment of type 2 diabetes, such as the Look AHEAD study [104–
107].
Figure 2. Schematic representation of PRT and its role in metabolic fitness. 
Legend: OA osteoarthritis; HbA1c glycosylated haemoglobin.
In summary, because of its manifold benefits, physical activity has been described as 
an important ‘medicine’ for the treatment of type 2 diabetes [108]. Moreover, the non-
pharmacological nature of physical activity and the low cost of exercise programs also 
The role of physical activity in the prevention and treatment of diabetes  • 287
makes this intervention appealing [97]. Nevertheless, physical activity is still underutilised 
in clinical settings to manage diabetes [60, 109–111].
Recommendations for diabetes management
Individually tailored and structured physical activity programs are important in the 
management of diabetes [110]. For instance, the patient’s age, aerobic fitness, muscle 
strength, body composition, previous level of physical activity, timing and doses of insulin 
and oral hypoglycaemic agents, and comorbidities and diabetic complications should 
be considered in exercise prescriptions for individuals with type 2 diabetes [43, 58]. In 
particular, co-existent osteoarthritis, cardiovascular disease, orthostatic hypotension, 
peripheral vascular disease, and peripheral neuropathy, all common in type 2 diabetes, 
will influence the modality and intensity of exercise, the need for supervision, and other 
specific recommendations.
To improve glycaemic control, support weight maintenance, and reduce the risk of 
cardiovascular disease, the American Diabetes Association (ADA) and the Amercian 
College of Sports Medicine (ACSM) recommends individuals with type 2 diabetes to 
engage in at least 150 minutes per week of moderate-intensity physical activity (40%–60% 
of VO2max, which equates to 50%–70% of the maximum heart rate) or at least 60 minutes 
per week of vigorous aerobic exercise (>60% of VO2max or >70% of maximum heart rate) 
[43, 112]. Engaging in moderate to vigorous aerobic and/or resistance training yields greater 
benefits in the reduction of cardiovascular risk than lower volumes of physical activity [43], 
and an increased volume of activity is required for weight loss [43, 51]. Depending on the 
duration and intensity of physical activity the increased insulin sensitivity lasts for 24 to 
72 hours after an activity session [113]. This underlines the importance of regular physical 
activity and therefore it is recommended that individuals with type 2 diabetes should not 
have more than two consecutive days without physical activity [43, 112].
Physical activity recommendations for adults with type 2 diabetes traditionally focused 
on aerobic activities, such as walking [114]. However, recent evidence has highlighted 
the effects of resistance training in addition to aerobic activities. Based on the substantial 
evidence that highlights the benefits of resistance and aerobic training, a combination of 
both exercise modalities appears optimal [76]. This is also stated in the recommendations 
for the general population of the American College of Sports Medicine, the American 
Diabetes Association, the American Heart Association, and the US Department of Health 
and Human Services that highlight the importance of incorporating resistance training 
into physical activity, especially for older adults [1, 3, 7, 112].
Pre-exercise screening should be considered for patients with type 2 diabetes. 
Screening should consider retinal disease, osteoarthritis, orthostatic hypotension, 
occult  cardiovascular disease, peripheral vascular disease, peripheral neuropathy and 
diabetic foot disease, depression, cognitive impairment and gait and balance disorders to 
reduce potential risks and guide the specific exercise recommendations relevant to each 
individual.
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There have been some concerns among medical practitioners about health risks associated 
with high-intensity resistance training for older adults. Particularly, these concerns are about 
acute elevation of blood pressure and an increase in risk of stroke, myocardial infarction, 
and retinal haemorrhage. However, there is no evidence that resistance training actually 
increases the risk of such events [43]. In fact, chronic resistance training is associated with 
lower blood pressure [77, 115] and lower risk of cardiovascular events and mortality [116].
Physical activity and diabetes complications
People with diabetes have at least twice the risk of incident and fatal cardiovascular events 
compared to the general population [117–119]. Furthermore, people with diabetes with 
low cardio-respiratory fitness have a higher risk of overall mortality than those with higher 
fitness levels [120]. Physical activity improves fitness and reduces the risk of cardiovascular 
disease substantially, which makes an active lifestyle particularly important for people with 
diabetes [74].
Additionally, diabetes is associated with other medical comorbidity, including retinopathy, 
peripheral neuropathy, orthostatic hypotension, mobility impairment, osteoarthritis, 
peripheral vascular disease and renal disease. These can limit exercise capacity among 
patients with diabetes. Therefore, it is of particular importance for people with diabetes 
in the early stages to commence regular exercise [121]. Specific exercise regimens may be 
required in the presence of diabetic complications. For instance, patients with peripheral 
neuropathy may benefit from non-weight-bearing activities, such as resistance training, 
swimming or cycling [43]. Among patients with autonomic neuropathy or receiving beta-
blockers, perceived exertion rather than the heart rate should be used to adjust the intensity 
of physical activity [109], and pre-exercise cardiac testing should be carried out before 
embarking on vigorous activity regimens in anyone with elevated cardiovascular risk, 
which includes most people with type 2 diabetes [88].
There are no known adverse effects of either resistance or aerobic training on vision or the 
progression of diabetic retinopathy. However, for patients with proliferative or severe non-
proliferative retinopathy, moderate physical activity is recommended as vigorous exercise 
could potentially trigger vitreous haemorrhage or retinal detachment [43]. 
Blood glucose monitoring may be important before, during and after prolonged exercise. 
Acute bouts of exercise may require adjustment of medications on exercise days to prevent 
hypoglycaemia, the latter which may otherwise occur during exercise or many hours 
afterwards including nocturnally. Exercise may be timed for the post prandial peak in 
blood glucose; this will reduce the risk of exercise-related hypoglycaemia as well as reduce 
post-prandial hyperglycaemia and hyperinsulinemia [43, 122].
Challenges in implementation
There is substantial evidence for the health benefits of physical activity and exercise in the 
management of type 2 diabetes. However, as reported in studies from the US [123], Canada 
[59, 124] and Australia [110] the proportion of people with type 2 diabetes meeting the 
minimal physical activity recommendations is significantly lower than in the age-matched 
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general population. An Australian population study reported significant gaps in physical 
activity recommendations and uptake as part of widespread diabetes management [110].
The principles of behaviour change are needed to encourage physical activity in the treatment 
of diabetes [59, 91, 111, 125]. Factors that facilitate or impede aerobic or resistance training 
need to be identified and addressed in clinical counselling. For example, older adults with 
diabetic complications may have difficulties engaging in more vigorous aerobic activities, 
and resistance training might be a better option. A frequent barrier is program costs, or 
the cost of resistance training equipment, and the daunting prospects of activity among 
sedentary individuals [76]. Since it is difficult to provide ongoing one-on-one supervision 
in resistance or aerobic training, understanding the maintenance of skills is required in the 
transition from supervised to independent training. Some resistance training interventions 
show long-term effects on muscle strength and body composition, but not on glycaemic 
control [114, 126].
Conclusion
Physical activity and exercise are effective in both prevention and treatment of diabetes, 
metabolic syndrome and cardiovascular disease. Both aerobic and resistance training have 
important roles in diabetes prevention and treatment, and the choice depends upon patient 
preferences, the need for supervision and the availability of exercise facilities. Higher doses 
and intensities of exercise are generally more effective, although there is benefit in starting 
at low to moderate levels of exercise intensity and volume, in order to reduce high drop-
out rates and prevent overuse injuries [75]. For some patients, exercise regimens should 
commence with moderate-intensity physical activities such as brisk walking [127, 128]. 
High volumes of exercise and incidental physical activity are required for weight loss, but 
activity can produce losses of the metabolically critical visceral fat compartment without 
overall change in body weight, and this can be of substantial benefit. On account of the 
acute bout effects, exercise frequency should be at least three days per week or more.
In summary, exercise is as potent as oral hypoglycaemic agents for glucose homeostasis, 
does not cause weight gain like insulin and oral agents, and provides additional benefits 
for fitness, functional independence, body composition, and vascular comorbidities which 
cannot be gained with pharmacologic or nutritional treatment alone. Thus, it should be 
seen as core to the prevention and treatment of type 2 diabetes, rather than an optional 
additional management strategy.
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